ARTICLE | Company News
Immusol, Baylor College of Medicine deal
February 6, 2006 8:00 AM UTC
Baylor granted Immusol an exclusive worldwide license to a preclinical oncolytic viral therapy to treat solid tumors. The therapy uses herpes simplex viruses. ...